Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

May 25, 2020 Issue

09820-cover-opener.jpg

May 25, 2020 Cover

Volume 98, Issue 20

Once thought to boost levels of ACE2, the novel coronavirus’s doorway into human cells, these widely used medicines are now contenders to treat the respiratory disease

Cover image:Rethinking the role of blood pressure drugs in COVID-19


Credit: C&EN/Protein Data Bank, PDB ID 1R42

Full Article
Volume 98 | Issue 20

All Issues

Quote of the Week

“It’s a yin and yang between how much angiotensin II is made, and how much is broken down.”

Matthew Sparks, nephrologist and assistant professor of medicine, Duke University

Infectious disease

Rethinking the role of blood pressure drugs in COVID-19

Once thought to boost levels of ACE2, the novel coronavirus’s doorway into human cells, these widely used medicines are now contenders to treat the respiratory disease

  • A chemist’s guide to disinfectants

    Has your local store run out of sanitizing wipes? This cheat sheet can help you find and understand alternatives

  • Tracking air quality in the Arctic atmosphere

    University of Michigan chemist Kerri Pratt and her team study climate-critical reactions with mass spectrometry

ADVERTISEMENT
image name
Vaccines

Moderna provides cursory glance at first COVID-19 vaccine data

The firm says its experimental mRNA vaccine is safe and induced promising levels of antibodies in a small Phase I clinical trial

ADVERTISEMENT
ADVERTISEMENT